Keloids: A viral hypothesis

Medical Hypotheses

Volumn 70, Issue 1, 2008, Pages 156-166

  Alonso, Pedro E ^a   Rioja, Luis F ^b   Pera, Carlos ^c  

^a Hospital USP Marbella   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c Universidad de Cordoba   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; BONE MARROW; CHEMOTAXIS; CLINICAL FEATURE; DELTOID MUSCLE; FIBROCYTE; FOMITE; GENETIC SUSCEPTIBILITY; HAND; HUMAN; HYPOTHESIS; INFECTION; KELOID; LYMPHATIC SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; SALIVA; SKIN; STERNUM; TISSUE REPAIR; VIRION; VIRUS; VIRUS LOAD; WOUND HEALING;

ADOLESCENT; CICATRIX; DISEASE RESERVOIRS; FEMALE; HUMANS; KELOID; MALE; MODELS, BIOLOGICAL; RECURRENCE; VIRUSES; WOUND HEALING;

EID: 36349015321     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.03.023     Document Type: Article

References (84)

1. Cohen I.K., and Peacock E.E. Keloids and hypertrophic scars. In: McCarthy J.G. (Ed). Plastic surgery (1990), Saunders 732-747
2. Pierce H.E. Keloids: enigma of the plastic surgeon. J Natl Med Assoc 71 (1979) 1177-1180
3. Mowlem R. Hypertrophic scars. Br J Plast Surg 4 (1951) 113-120
4. Crockett D.J. Regional keloid susceptibility. Br J Plast Surg 17 (1964) 245-253
5. Yagi K.I., Dafalla A.A., and Osman A.A. Does an immune reaction to sebum in wounds cause keloid scars? Beneficial effect of desensitisation. Br J Plast Surg 32 (1979) 223-225
6. Kischer C.W., Thies A.C., and Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scar and keloids. Hum Pathol 13 (1982) 819-824
7. Topol B.M., Lewis V.L., and Benveniste K. The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar, and keloid. Plast Reconstr Surg 68 (1981) 227-230
8. Sayah D.N., Soo C., Shaw W.W., et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 87 (1999) 209-216
9. Smith C.J., Smith J.C., and Finn M.C. The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. J Burn Care Rehabil 8 (1987) 126-131
10. Al-Attar A., Mess S., Thomassen J.M., Kauffman C.L., and Davison S.P. Keloid pathogenesis and treatment. Plast Reconstr Surg 117 (2006) 286-300
11. Brenizer A.G. Keloid formation in the Negro. Ann Surg 61 (1915) 83-87
12. Warren J.R., and Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 321 8336 (1983) 1273-1275
13. Chang Y., Cesarman E., Pessin M.S., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
14. Walboomers J.M.M., Jacobs M.V., Manos M.M., et al. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
15. Lorber B. Are all diseases infectious?. Ann Intern Med 125 (1996) 844-851
16. O'Connor S.M., Taylor C.E., and Hughes J.M. Emerging infectious determinants of chronic diseases. Emerg Infect Dis 12 (2006) 1051-1057
17. Coen D.M., and Richman D.D. Antiviral agents. In: Knipe D.M., and Howley P.M. (Eds). Fields virology (2007), Lippincott Williams and Wilkins, A Wolters Kluwer Business, Philadelphia 447-485
18. Lipke M.M. An armamentarium of wart treatments. Clin Med Res 4 (2006) 273-293
19. Perez C.A., Lockett M.A., and Young G. Radiation therapy for keloids and plantar warts. Front Radiat Ther Oncol 35 (2001) 135-146
20. Zamiri M., and Gupta G. Plantar warts treated with an immune response modifier: a report of two cases. Clin Exp Dermatol 28 Suppl. 1 (2003) 45-47
21. Stashower M.E. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatol Surg 32 (2006) 380-386
22. Dahl M.V. Imiquimod: an immune response modifier. J Am Acad Dermatol 43 (2000) S1-S5
23. Skinner R.B. Imiquimod. Dermatol Clin 21 (2003) 291-300
24. Whitaker J.M., Gaggero G.L., Loveland L., Segura L., and Barbosa P. Plantar verrucae in patients with human immunodeficiency virus. Clinical presentation and treatment response. J Am Podiatr Med Assoc 91 (2001) 79-84
25. Marini A., Niehues T., Stege H., Ruzicka T., and Hengge U.R. Plantar warts in twins after successful bone marrow transplantation for severe combined immunodeficiency. J Dtsch Dermatol Ges 4 (2006) 417-420
26. Azurdia R.M., Graham R.M., Weismann K., Guerin D.M., and Parslew R. Acne keloidalis in Caucasian patients on cyclosporin following organ transplantation. Br J Dermatol 143 (2000) 465-467
27. Shivaswamy K.N., and Thappa D.M. Extensive keloids following cyclosporin therapy in a pemphigus vulgaris patient. J Eur Acad Dermatol Venereol 21 (2007) 111-112
28. Rockwell W.B., Cohen I.K., and Ehrlich H.P. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 84 (1989) 827-837
29. Niessen F.B., Spauwen P.H., Schalkwijk J., and Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104 (1999) 1435-1458
30. Alhady S.M., and Sivanantharajah K. Keloids in various races: a review of 175 cases. Plast Reconstr Surg 44 (1969) 564-566
31. Oluwasanmi J.O. Keloids in the African. Clin Plast Surg 1 (1974) 179-195
32. Ketchum L.D., Cohen I.K., and Masters F.W. Hypertrophic scars and keloids. A collective review. Plast Reconstr Surg 53 (1974) 140-154
33. Moustafa M.F., Abdel-Fattah M.A., and Abdel-Fattah D.C. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Case report. Plast Reconstr Surg 56 (1975) 450-453
34. George A.O., Akanji A.O., Nduka E.U., Olasode J.B., and Odusan O. Clinical, biochemical and morphologic features of acne keloidalis in a black population. Int J Dermatol 32 (1993) 714-716
35. Mysliwska J., Trzonkowski P., Bryl E., Lukaszuk K., and Mysliwski A. Lower interleukin-2 and higher serum tumor necrosis factor-a levels are associated with perimenstrual, recurrent, facial Herpes simplex infection in young women. Eur Cytokine Netw 11 (2000) 397-406
36. Bloom D. Heredity of keloids: review of the literature and report of a family with multiple keloids in five generations. NY State J Med 56 (1956) 511-519
37. Bayat A., Walter J.M., Bock O., Mrowietz U., Ollier W.E.R., and Ferguson M.W.J. Genetic susceptibility to keloid disease: mutation screening of the TGFb3 gene. Brit J Plast Surg 58 (2005) 914-921
38. Appelmelk B.J., Simoons-Smit I., Negrini R., et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 64 (1996) 2031-2040
39. Martin C.W., and Muir I.F.K. The role of lymphocytes in wound healing. Br J Plast Surg 43 (1990) 655-662
40. Bucala R., Spiegel L.A., Chesney J., Hogan M., and Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1 (1994) 71-81
41. Stirling G.A., and Kakkar V.V. Cells in the circulating blood capable of producing connective tissue. Br J Exp Pathol 50 (1969) 51-55
42. Quan T.E., Cowper S., Wu S.P., Bockenstedt L.D., and Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36 (2004) 598-606
43. García-Ulloa A.C., and Arrieta O. Tubal occlusion causing infertility due to an excessive inflammatory response in patients with predisposition for keloid formation. Med Hypotheses 65 (2005) 908-914
44. Raman R., Arumainathan U., Subramaniam S., Chan L., and Jalaludin M.A. Hypertrophic scars, keloids, and laryngotracheal stenosis. Plast Reconstr Surg 103 (1999) 1539
45. Haahr S., and Munch M. The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus. J Neurovirol 6 Suppl. 2 (2000) S76-S79
46. Muir I.F.K. On the nature of keloid and hypertrophic scars. Br J Plast Surg 43 (1990) 61-69
47. Brown D.L., Kao W.W., and Greenhalgh D.G. Apoptosis down-regulates inflammation under the advancing epithelial wound edge: delayed patterns in diabetes and improvement with topical growth factors. Surgery 121 (1997) 372-380
48. Desmouliere A., Redard M., Darby I., and Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146 (1995) 56-66
49. Calderon M., Lawrence W.T., and Banes A.J. Increased proliferation of keloid fibroblasts wounded in vitro. J Surg Res 61 (1996) 343-347
50. Luo S., Benathan M., Raffoul W., Panizzon R.G., and Egloff D.V. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 107 (2001) 87-96
51. Diegelmann R.F., Cohen I.K., and McCoy B.J. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 98 (1979) 341-346
52. Ladin D.A., Hou Z., Patel D., et al. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Rep Reg 6 (1998) 28-37
53. Boya P., Pauleau A.L., Panceta D., González-Polo R.A., Zamzami N., and Kroemer G. Viral proteins targeting mitochondria: controlling cell death. Biochim Biophys Acta 1659 (2004) 178-189
54. Curreli F., Friedman-Kien A.E., and Flore O. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J Clin Invest 115 (2005) 642-652
55. Klass C.M., Krug L.T., Pozharskaya V.P., and Offermann M.K. The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood 105 (2005) 4028-4034
56. Lee T.Y., Chin G.S., Kim W.J., Chau D., Gittes G.K., and Longaker M.T. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43 (1999) 179-184
57. Bettinger D.A., Yager D.R., Diegelmann R.F., and Cohen I.K. The effect of TGF-β on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 98 (1996) 827-833
58. Chodon T., Sugihara T., Igawa H.H., Funayama E., and Furukawa H. Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 157 (2000) 1661-1669
59. Chin G.S., Liu W., Peled Z., et al. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108 (2001) 423-429
60. Michelson S., Alcami J., Kim S.-J., et al. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor β1. J Virol 68 (1994) 5730-5737
61. Boyce D.E., Ciampolini J., Ruge E., Murison M.S.C., and Harding K.G. Inflammatory cell subpopulations in keloid scars. Br J Plast Surg 54 (2001) 511-516
62. Cohen I.K., McCoy B.J., Mohanakumar T., and Diegelmann R.F. Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 63 (1979) 689-695
63. Giovannoni G., Cutter G.R., Lunemann J., et al. Infectious causes of multiple sclerosis. Lancet Neurol 5 (2006) 887-894
64. Marshall B.J., Armstrong J.A., McGechie D.B., and Glancy R.J. Attempt to fulfill the Koch's postulates for pyloric Campylobacter. Med J Austral 142 (1985) 436-439
65. Blaser M.J. The role of Helicobacter pylori in gastritis and its progression to peptic ulcer disease. Aliment Pharmacol Ther 9 Suppl. 1 (1995) 27-30
66. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
67. Fredericks D.N., and Relman D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 9 (1996) 18-33
68. Yang L., Scott P.G., Giuffre J., Shankowsky H.A., Ghahary A., and Tredget E.E. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82 (2002) 1183-1192
69. Datubo-Brown D.D. Keloids: a review of the literature. Br J Plast Surg 43 (1990) 70-77
70. Ginarte M., Peteiro C., and Toribio J. Keloid formation induced by isotretinoin therapy. Int J Dermatol 38 (1999) 228-229
71. Zachariae H. Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br J Dermatol 118 (1988) 703-706
72. Cruz N.I., and Korchin L. Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg 33 (1994) 401-405
73. Daly T.J., Golitz L.E., and Weston W.L. A double-blind placebo-controlled efficacy study of tretinoin cream 0.05% in the treatment of keloids and hypertrophic scars (Abstract). J Invest Dermatol 86 (1986) 470
74. Coppa L.M., Alam M., Longley B.J., and Stiller M.J. Eruptive paraneoplastic keloids. Cutis 64 (1999) 243-244
75. Raoult D., Birg M.L., La Scola B., et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med 342 (2000) 620-625
76. Ketchum L.D., Robinson D.W., and Masters F.W. Follow-up on treatment of hypertrophic scars and keloids with triamcinolone. Plast Reconstr Surg 48 (1971) 256-259
77. McCoy B.J., Diegelmann R.F., and Cohen I.K. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 163 (1980) 216-222
78. Tang Y.W., Johnson J.E., Browning P.J., et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 41 (2003) 2633-2640
79. Harley J.B., Harley I.T.W., Guthridge J.M., and James J.A. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 15 (2006) 768-777
80. Tsekouras A.A., and McGeorge D.D. Palmar fasciectomy and keloid formation. Br J Plast Surg 52 (1999) 593-594
81. Aslan G., Terzioglu A., and CigSar B. A massive plantar keloid. Ann Plast Surg 47 (2001) 581
82. Osswald S.S., Elston D.M., and Vogel P.S. Giant right plantar keloid treated with excision and tissue-engineered allograft. J Am Acad Dermatol 48 (2003) 131-134
83. González-Martínez R., Marín-Bertolín S., and Amorrortu-Velayos J. Association between keloids and Dupuytren's disease: case report. Br J Plast Surg 48 (1995) 47-48
84. Magro C.M., Crowson A.N., and Ferri C. Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change. Hum Pathol 38 (2007) 42-49